XML 31 R13.htm IDEA: XBRL DOCUMENT v3.20.1
8. Stockholders' Equity
9 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Stockholders' Equity

8. Stockholders’ Equity

 

 Stock Incentive Plans

 

Our stock incentive plans permit the granting of stock options (both incentive and nonqualified stock options), RSUs, stock appreciation rights, non-vested stock, and performance shares to certain employees, directors and consultants. As of March 31, 2020, no stock appreciation rights or non-vested stock was outstanding.

  

Stock Options

 

The following table presents a summary of activity during the nine months ended March 31, 2020 with respect to our stock options:

 

        Weighted- 
        Average 
    Number of   Exercise Price 
    Shares   per Share 
     (In thousands)      
Balance of options outstanding at June 30, 2019    3,147   $2.29 
Granted    248    3.33 
Forfeited    (179)   2.35 
Expired    (76)   2.21 
Exercised    (834)   1.76 
Balance of options outstanding at March 31, 2020    2,306   $2.58 

 

Restricted Stock Units

 

The following table presents a summary of activity during the nine months ended March 31, 2020 with respect to our RSUs:

 

        Weighted- 
        Average 
        Grant Date 
    Number of   Fair Value 
    Shares   per Share 
     (In thousands)      
Balance of RSUs outstanding at June 30, 2019    866   $4.24 
Granted    431    3.32 
Vested    (203)   4.68 
Forfeited    (109)   3.76 
Balance of RSUs outstanding at March 31, 2020    985   $3.80 

 

Performance Stock Units

 

In October 2019, we granted 975,000 RSUs with performance-based vesting requirements (“performance stock units” or “PSUs”) to certain executive employees. In February 2020, we granted an additional 70,000 RSUs with performance-based vesting requirements and vesting schedule identical to those granted in October 2019. One third of the PSUs will be eligible to vest in each of the three years beginning in fiscal 2020 if certain earnings per share, revenue targets and market conditions are met. The estimate of the grant date fair value and related share-based compensation expense included the use of a Monte Carlo simulation which incorporates estimates of the potential outcomes of the market condition of these awards.

 

Employee Stock Purchase Plan

 

Our 2013 Employee Stock Purchase Plan (“ESPP”) is intended to provide employees with an opportunity to purchase our common stock through accumulated payroll deductions at the end of a specified purchase period. Each of our employees (including officers) is eligible to participate in our ESPP, subject to certain limitations as set forth in our ESPP.

   

The following table presents a summary of activity under our ESPP during the nine months ended March 31, 2020:

 

    Number of 
    Shares 
     (In thousands) 
Shares available for issuance at June 30, 2019    517 
Shares issued    (64)
Shares available for issuance at March 31, 2020    453 

 

Share-Based Compensation Expense

 

The following table presents a summary of share-based compensation expense included in each functional line item on our accompanying unaudited condensed consolidated statements of operations:

 

   Three Months Ended   Nine Months Ended 
   March 31,   March 31, 
   2020   2019   2020   2019 
   (In thousands) 
Cost of revenue  $70   $22   $142   $62 
Selling, general and administrative   939    213    2,176    950 
Research and development   123    96    331    248 
Total share-based compensation expense  $1,132   $331   $2,649   $1,260 

 

The following table presents the remaining unrecognized share-based compensation expense related to our outstanding share-based awards as of March 31, 2020:

 

   Remaining   Remaining 
   Unrecognized   Weighted- 
   Compensation   Average Years 
   Expense   To Recognize 
    (In thousands)      
Stock options  $1,494    2.6 
RSUs   3,309    3.2 
PSUs   1,205    2.3 
Stock purchase rights under ESPP   13    0.1 
   $6,021      

 

If there are any modifications or cancellations of the underlying unvested share-based awards, we may be required to accelerate, increase or cancel remaining unearned share-based compensation expense. Future share-based compensation expense and unearned share-based compensation will increase to the extent that we grant additional share-based awards.